DRNA
Dicerna Pharmaceuticals Inc
Price:  
38.22 
USD
Volume:  
5,675,030.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DRNA EV/EBITDA

-179.0%
Upside

As of 2025-07-12, the EV/EBITDA ratio of Dicerna Pharmaceuticals Inc (DRNA) is -22.81. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DRNA's latest enterprise value is 2,729.79 mil USD. DRNA's TTM EBITDA according to its financial statements is -119.65 mil USD. Dividing these 2 quantities gives us the above DRNA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 13.5x - 14.2x 13.8x
Forward P/E multiples 23.2x - 30.9x 27.2x
Fair Price (34.42) - (20.18) (30.19)
Upside -190.1% - -152.8% -179.0%
38.22 USD
Stock Price
(30.19) USD
Fair Price

DRNA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA